Alnylam Pharmace. buy RudolfL
Start price
29.07.26
/
50%
€253.70
Target price
29.08.26
€270.00
Performance (%)
-24.81%
End price
30.07.26
€190.75
Summary
This prediction ended on 30.07.26 with a price of €190.75. The prediction for Alnylam Pharmace. disappointed with a performance of -24.81%. RudolfL has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w |
|---|---|
| Alnylam Pharmace. | -24.81% |
| iShares Core DAX® | 2,59 % |
| iShares Nasdaq 100 | -0,91 % |
| iShares Nikkei 225® | 0,15 % |
| iShares S&P 500 | -0,37 % |
Comments by RudolfL for this prediction
In the thread Alnylam Pharmace. diskutieren
Kursziel gesetzt auf 270,0
In the thread Trading Alnylam Pharmace.
Stopped prediction by RudolfL for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€88.35
19.11.19
19.11.19
€140.00
04.11.21
04.11.21
15.29%
10.12.20
10.12.20
